NVDA+0.63%AAPL-1.47%

GOOGL-0.35%

MSFT-0.79%AMZN-1.62%

BTC-0.51%

AVGO-5.58%

TSM-1.45%

VOO-0.15%

LLY+3.43%

WMT+0.09%

JPM+0.47%

V-0.27%

BP-0.03%

ORCL-2.71%

JNJ+1.23%

MA-0.48%

XOM-0.89%

ASML+0.68%

BAC+0.41%

ABBV+1.89%

QQQ-0.51%

BND+0.12%

HD-0.73%

BABA-3.59%

PG+1.61%

GE+0.39%

CSCO+0.57%

UNH-0.27%

KO+0.65%

WFC+0.15%

CVX-0.09%

IBM-0.1%

SAP-0.19%

AZN+1.93%

MS-0.35%

TM+3.24%

GS+0.18%

CAT-1.32%

VTI-0.15%

AXP0%

MU-1.51%

NVS+1.98%

HSBC+0.37%

MRK+0.06%

PM+2.99%

RTX+1.93%

CRM-3.04%

RY+0.74%

APP+0.66%

MCD+0.65%

NVO+0.42%

ABT+2.49%

TMUS+0.5%

TMO+0.61%

C+0.89%

SHEL-0.14%

AMAT+0.83%

PEP+0.37%

LRCX+2.38%

ISRG+3.18%

LIN+0.18%

QCOM+0.56%

GEV+1.44%

INTU-2.45%

BX-0.56%

BKNG+2.96%

AMGN+2.38%

TJX+0.41%

SCHW-1.42%

T-1.02%

VZ0%

ACN+1.27%

NEE+0.06%

BLK-0.64%

DHR+0.99%

TXN-0.81%

KLAC+2.62%

SONY-0.49%

APH+0.51%

NOW-11.6%

ANET+0.93%

TD+0.66%

PDD-1.41%

COF+0.82%

SPGI-0.32%

PFE+2.26%

NVDA+0.63%AAPL-1.47%

GOOGL-0.35%

MSFT-0.79%AMZN-1.62%

BTC-0.51%

AVGO-5.58%

TSM-1.45%

VOO-0.15%

LLY+3.43%

WMT+0.09%

JPM+0.47%

V-0.27%

BP-0.03%

ORCL-2.71%

JNJ+1.23%

MA-0.48%

XOM-0.89%

ASML+0.68%

BAC+0.41%

ABBV+1.89%

QQQ-0.51%

BND+0.12%

HD-0.73%

BABA-3.59%

PG+1.61%

GE+0.39%

CSCO+0.57%

UNH-0.27%

KO+0.65%

WFC+0.15%

CVX-0.09%

IBM-0.1%

SAP-0.19%

AZN+1.93%

MS-0.35%

TM+3.24%

GS+0.18%

CAT-1.32%

VTI-0.15%

AXP0%

MU-1.51%

NVS+1.98%

HSBC+0.37%

MRK+0.06%

PM+2.99%

RTX+1.93%

CRM-3.04%

RY+0.74%

APP+0.66%

MCD+0.65%

NVO+0.42%

ABT+2.49%

TMUS+0.5%

TMO+0.61%

C+0.89%

SHEL-0.14%

AMAT+0.83%

PEP+0.37%

LRCX+2.38%

ISRG+3.18%

LIN+0.18%

QCOM+0.56%

GEV+1.44%

INTU-2.45%

BX-0.56%

BKNG+2.96%

AMGN+2.38%

TJX+0.41%

SCHW-1.42%

T-1.02%

VZ0%

ACN+1.27%

NEE+0.06%

BLK-0.64%

DHR+0.99%

TXN-0.81%

KLAC+2.62%

SONY-0.49%

APH+0.51%

NOW-11.6%

ANET+0.93%

TD+0.66%

PDD-1.41%

COF+0.82%

SPGI-0.32%

PFE+2.26%

Teladoc Health (TDOC) AI Price Prediction | TrendEdge | TrendEdge

NVDA+0.63%AAPL-1.47%

GOOGL-0.35%

MSFT-0.79%AMZN-1.62%

BTC-0.51%

AVGO-5.58%

TSM-1.45%

VOO-0.15%

LLY+3.43%

WMT+0.09%

JPM+0.47%

V-0.27%

BP-0.03%

ORCL-2.71%

JNJ+1.23%

MA-0.48%

XOM-0.89%

ASML+0.68%

BAC+0.41%

ABBV+1.89%

QQQ-0.51%

BND+0.12%

HD-0.73%

BABA-3.59%

PG+1.61%

GE+0.39%

CSCO+0.57%

UNH-0.27%

KO+0.65%

WFC+0.15%

CVX-0.09%

IBM-0.1%

SAP-0.19%

AZN+1.93%

MS-0.35%

TM+3.24%

GS+0.18%

CAT-1.32%

VTI-0.15%

AXP0%

MU-1.51%

NVS+1.98%

HSBC+0.37%

MRK+0.06%

PM+2.99%

RTX+1.93%

CRM-3.04%

RY+0.74%

APP+0.66%

MCD+0.65%

NVO+0.42%

ABT+2.49%

TMUS+0.5%

TMO+0.61%

C+0.89%

SHEL-0.14%

AMAT+0.83%

PEP+0.37%

LRCX+2.38%

ISRG+3.18%

LIN+0.18%

QCOM+0.56%

GEV+1.44%

INTU-2.45%

BX-0.56%

BKNG+2.96%

AMGN+2.38%

TJX+0.41%

SCHW-1.42%

T-1.02%

VZ0%

ACN+1.27%

NEE+0.06%

BLK-0.64%

DHR+0.99%

TXN-0.81%

KLAC+2.62%

SONY-0.49%

APH+0.51%

NOW-11.6%

ANET+0.93%

TD+0.66%

PDD-1.41%

COF+0.82%

SPGI-0.32%

PFE+2.26%

NVDA+0.63%AAPL-1.47%

GOOGL-0.35%

MSFT-0.79%AMZN-1.62%

BTC-0.51%

AVGO-5.58%

TSM-1.45%

VOO-0.15%

LLY+3.43%

WMT+0.09%

JPM+0.47%

V-0.27%

BP-0.03%

ORCL-2.71%

JNJ+1.23%

MA-0.48%

XOM-0.89%

ASML+0.68%

BAC+0.41%

ABBV+1.89%

QQQ-0.51%

BND+0.12%

HD-0.73%

BABA-3.59%

PG+1.61%

GE+0.39%

CSCO+0.57%

UNH-0.27%

KO+0.65%

WFC+0.15%

CVX-0.09%

IBM-0.1%

SAP-0.19%

AZN+1.93%

MS-0.35%

TM+3.24%

GS+0.18%

CAT-1.32%

VTI-0.15%

AXP0%

MU-1.51%

NVS+1.98%

HSBC+0.37%

MRK+0.06%

PM+2.99%

RTX+1.93%

CRM-3.04%

RY+0.74%

APP+0.66%

MCD+0.65%

NVO+0.42%

ABT+2.49%

TMUS+0.5%

TMO+0.61%

C+0.89%

SHEL-0.14%

AMAT+0.83%

PEP+0.37%

LRCX+2.38%

ISRG+3.18%

LIN+0.18%

QCOM+0.56%

GEV+1.44%

INTU-2.45%

BX-0.56%

BKNG+2.96%

AMGN+2.38%

TJX+0.41%

SCHW-1.42%

T-1.02%

VZ0%

ACN+1.27%

NEE+0.06%

BLK-0.64%

DHR+0.99%

TXN-0.81%

KLAC+2.62%

SONY-0.49%

APH+0.51%

NOW-11.6%

ANET+0.93%

TD+0.66%

PDD-1.41%

COF+0.82%

SPGI-0.32%

PFE+2.26%

Teladoc Health AI Price Prediction

TDOC • NYSE

Similar Stocks

VEEV

$219.73

-1.58%

6

AI Score

DOCS

$44.65

1.82%

6

AI Score

AMWL

Alternative Data Insights

Unlock comprehensive alternative data signals to make better investment decisions

Web Traffic

Data visualization

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Current Value

Daily Change

Weekly Change

1 Month Change

3 Month Change

6 Month Change

🔒

Unlock Premium Data

Get access to real-time alternative data and insights

Start 7-Day Free Trial

TDOC AI Stock Analysis

Financial Performance

bearish

Teladoc Health remains unprofitable, as indicated by its negative EPS of -1.26 and a negative PE ratio of -5.83. While these figures do not capture revenue growth or gross margin directly, they signal that the company is still struggling to convert its business scale into sustainable earnings. Until there is a clear path to profitability, the financial profile leans negative from an equity-holder perspective.

Negative EPS of -1.26 and a PE ratio of -5.83 indicate ongoing net losses and an absence of earnings support for the current valuation.
The lack of profitability suggests that, despite likely meaningful revenue and gross profit, operating expenses and/or non-cash charges are still outweighing income.
Equity investors are currently relying on future turnaround and growth expectations rather than demonstrated earnings power, which elevates risk in the absence of improving profit metrics.

Stock Price & Technicals

neutral

At $7.35, Teladoc Health is trading modestly below its 200-day moving average of $7.79, suggesting the broader trend is still slightly downward or at best sideways. The 5.0% gain over the last month shows some short-term strength, but the RSI of 34.31 is near oversold territory, indicating recent selling pressure and subdued momentum. Overall, the technical picture points to a cautious, range-bound setup rather than a clear bullish or bearish breakout.

Price of $7.35 is below the 200-day moving average of $7.79, which typically reflects a weak or non-confirmed long-term uptrend.
RSI at 34.31 is close to the oversold threshold (30), implying the stock has experienced recent downside pressure but could be approaching a potential support area.
The stock is up 5.0% in the last month, suggesting a short-term bounce, yet this has not been strong enough to reclaim the longer-term moving average and reverse the broader trend.

Alternative Data Signals

bullish

Alternative data for Teladoc Health is broadly positive, with particularly strong momentum in app downloads and modest growth in hiring and social media presence. Estimated mobile app downloads of 175,000 per day, up 150% month over month, signal accelerating user engagement and potential future revenue opportunities. Rising job openings and generally growing social media followings support a narrative of continued investment in growth and brand visibility.

Mobile app downloads are an estimated 175,000 per day, up 150.0% month over month, indicating sharply rising user acquisition and engagement, which is a strong leading indicator for platform usage and potential revenue growth.
Job openings at 87, up 10.1% month over month, suggest the company is selectively expanding its workforce, consistent with ongoing investment in product, technology, or commercial capabilities rather than contraction.
Web traffic at about 950,636 monthly visitors and mostly growing social media followings (Instagram, Facebook, YouTube, LinkedIn all up modestly) point to stable-to-improving brand reach, with only a slight decline in Twitter/X followers that does not materially offset the broader positive trend.

Conclusion

neutral

Overall, the picture for Teladoc Health is mixed: alternative data and user growth dynamics are constructive, but the company remains unprofitable and the stock is technically weak to range-bound. The strong surge in app downloads and modest hiring growth support a positive long-term demand story, yet negative earnings and a price below the 200-day moving average temper the outlook. Taken together, these factors justify a neutral stance, with upside potential contingent on clearer progress toward profitability.

Persistent net losses and a negative PE ratio weigh against the otherwise encouraging signs of user and engagement growth, keeping the risk profile elevated.
Alternative data and modest technical stabilization (recent 1-month gain and near-oversold RSI) suggest the potential for improvement, but without confirmed earnings traction or a clear technical reversal, the overall view remains neutral rather than decisively bullish or bearish.